Evidence map›Paper›PMID 35841263›Full record

ArticleTransboundary and emerging diseases2022

Evidence of antibodies against SARS-CoV-2 in wild mustelids from Brittany (France).

Bernard Davoust, Patrick Guérin, Nicolas Orain, Camille Fligny, Fabien Flirden, Florence Fenollar, Oleg Mediannikov, Sophie Edouard

Open access · hybridAbstract readObservational Study, Veterinary
In one paragraph

Article in Transboundary and emerging diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Bulletin de l'Academie nationale de medecine · 2022
    Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Bernard DavoustAix Marseille Univ, IRD, AP-HM, MEPHI, Marseille, France.ORCID https://orcid.org/0000-0002-7836-6809
Patrick GuérinOpenHealth Company, Vannes, France.
Nicolas OrainIHU Méditerranée Infection, Marseille, France.
Camille FlignyAix Marseille Univ, IRD, AP-HM, MEPHI, Marseille, France.
Fabien FlirdenAix Marseille Univ, IRD, AP-HM, MEPHI, Marseille, France.
Florence FenollarIHU Méditerranée Infection, Marseille, France.
Oleg MediannikovAix Marseille Univ, IRD, AP-HM, MEPHI, Marseille, France.
Sophie EdouardAix Marseille Univ, IRD, AP-HM, MEPHI, Marseille, France.
Aix-Marseille Université · FRMéditerranée Infection Foundation · FRThe Open Group · GB

Funding

Fondation Méditerranée InfectionOpenHealth Company
6 · The paper itself

Abstract

In the French region of Brittany, mainly in the department of the Côtes d'Armor, during the first half of 2021, seropositivity for SARS-CoV-2 was detected in five wild mustelids out of 33 animals tested (15.6%). Anti-SARS-CoV-2 IgG was detected against at least four out of five recombinant viral proteins (S1 receptor binding domain, nucleocapsid, S1 subunit, S2 subunit and spike) in three pine martens (Martes martes) and in two badgers (Meles meles) using the automated western blot technique. An ELISA test also identified seropositive cases, although these did not align with western blot results. Although the 171 qPCRs carried out on samples from the 33 mustelids were all negative, these preliminary results from this observational study nevertheless bear witness to infections of unknown origin. The epidemiological surveillance of Covid-19 in wildlife must continue, in particular with effective serology tools.

Indexed as

COVID-19MustelidaeAnimalsAntibodies, ViralImmunoglobulin GSARS-CoV-2Spike Glycoprotein, CoronavirusViral ProteinsAntibodies, ViralImmunoglobulin GSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Viral ProteinsCovid-19epidemiosurveillanceFranceMartes martesMeles melesmustelidsSARS-CoV-2serologywildlife

Identifiers

PMID35841263
PMCPMC9350122
OpenAlexW4285588849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.